WCN25-1780 ULTRASTRUCTURAL CHARECTORISTICS OF DIABETIC NEPHROPATHY AND ITS PREDICTIVE ROLE IN ASSESSING DISEASE PROGRESSION: A RETROSPECTIVE COHORT STUDY

WCN25-1780 ULTRASTRUCTURAL CHARECTORISTICS OF DIABETIC NEPHROPATHY AND ITS PREDICTIVE ROLE IN ASSESSING DISEASE PROGRESSION: A RETROSPECTIVE COHORT STUDY

Saved in:

Bibliographic Details
Main Authors:	sonu manuel, shashikiran kb, Rohan Dwivedi, Faizan Ansari, Anvesh Golla
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924025191
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4271 UNVEILING DIABETIC FIBRILLOSIS: CLINICAL AND ULTRASTRUCTURAL CORRELATIONS IN DIABETIC NEPHROPATHY
by: Avinash Thakur, et al.
Published: (2025-02-01)

WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY
by: Sherzod Abdullaev, et al.
Published: (2025-02-01)

WCN25-2987 2 CASES WITH IGM NEPHROPATHY
by: Nihal Bashir, et al.
Published: (2025-02-01)

WCN25-3861 Is it Membranous nephropathy in a case of Primary APLA?
by: Rahul Sai Gangula, et al.
Published: (2025-02-01)

WCN25-925 A RARE CASE OF AN INHERITED CRYSTALLINE NEPHROPATHY
by: Jawad Iqbal Rather, et al.
Published: (2025-02-01)

WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY
by: Kazuaki Mori, et al.
Published: (2025-02-01)

WCN25-4122 Rituximab in Primary Membranous Nephropathy- three years outcome
by: Prabjot Kaur Johal, et al.
Published: (2025-02-01)

WCN25-1964 PULMONARY HEMORRHAGES IN A PATIENT WITH Ig A NEPHROPATHY
by: Alok Kumar, et al.
Published: (2025-02-01)

WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING
by: Meghana Rao C, et al.
Published: (2025-02-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

WCN25-3843 IT IS NOT ALWAYS DIABETIC NEPHROPATHY: A CASE REPORT OF FIBRILLARY GLOMERULONEPHRITIS
by: Reima Almarshoodi, et al.
Published: (2025-02-01)

WCN25-1092 A STUDY OF CLINICOPATHOLOGICAL SPECTRUM AND OUTCOME OF PRIMARY MEMBRANOUS NEPHROPATHY
by: Muzamil ahmad wani, et al.
Published: (2025-02-01)

WCN25-4036 Improved Outcomes with an Additional Rituximab Dose in Primary Membranous Nephropathy
by: Vinod Kumar, et al.
Published: (2025-02-01)

WCN25-851 A RARE CASE OF OXALATE NEPHROPATHY ASSOCIATED WITH CARCINOID SYNDROME
by: Harshil Fichadiya, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

WCN25-608 FABRY DISEASE NEPHROPATHY: BIOMARKERS IN PATIENTS ON ENZYME REPLACEMENT THERAPY
by: Fernando Perretta, et al.
Published: (2025-02-01)

WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY
by: MANJARI BHAT, et al.
Published: (2025-02-01)

WCN25-4468 NELL-1 POSITIVE MEMBRANOUS NEPHROPATHY: FAIR IS NOT ALWAYS FAIR!
by: AMIT PASARI, et al.
Published: (2025-02-01)

WCN25-4202 NAVIGATING THE THERAPEUTIC LANDSCAPE: A RETROSPECTIVE EXPLORATION OF TREATMENT OUTCOMES IN PRIMARY MEMBRANOUS NEPHROPATHY
by: Utkarash Mishra, et al.
Published: (2025-02-01)

WCN25-4245 A CASE SERIES OF CONCURRENT IGA NEPHROPATHY AND ANTI- GBM DISEASE
by: Priyangani Lohia, et al.
Published: (2025-02-01)

WCN25-3234 FINRENONE IN DIABETIC NEPHROPATHY: REAL-WORLD EXPERIENCE FROM CENTRAL INDIA
by: Vijay Jeyachandran, et al.
Published: (2025-02-01)

WCN25-4432 BK Virus Nephropathy and Transplant Outcomes - A Single Center Study
by: Prashanta Ojha, et al.
Published: (2025-02-01)

WCN25-4091 OUTCOME OF PRIMARY MEMBRANOUS NEPHROPATHY IN DIABETIC AND NON-DIABETIC PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY
by: ELSA THOMAS, et al.
Published: (2025-02-01)

WCN25-3594 CLINICAL CHARACTERISTICS AND OUTCOMES OF PRIMARY MEMBRANOUS NEPHROPATHY IN 150 PATIENTS: A RETROSPECTIVE COHORT STUDY
by: Jaish George, et al.
Published: (2025-02-01)

WCN25-2220 PROPORTION OF RAPID PROGRESSION OF DIABETIC NEPHROPATHY AND THE FACTORS ASSOCIATED WITH IT AMONG PATIENTS ATTENDING A TERTIARY CARE CENTRE IN SOUTH INDIA
by: Gayathri Pillai, et al.
Published: (2025-02-01)

WCN24-1780 A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE
by: Mariana Ursino, et al.
Published: (2024-04-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-1613 GLUCOCORTICOID TOXICITY INDEX IN MEMBRANOUS NEPHROPATHY AND PODOCYTOPATHIES IN ADULT: A PILOT STUDY
by: RAJESH KUMAR, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-2007 Evaluation of treatment strategy in patients with IgA nephropathy with impaired renal function
by: Ryousuke Aoki, et al.
Published: (2025-02-01)

WCN25-1398 SECONDARY MEMBRANOUS NEPHROPATHY : LUPUS NEPHRITIS OR HEPATITIS B? – A DIAGNOSTIC DILEMMA
by: Sanjana Sharma, et al.
Published: (2025-02-01)

WCN25-4153 A RARE COMPLICATION POST HEMATOPOETIC STEM CELL TRANSPLANT - MEMBRANOUS NEPHROPATHY
by: DHEERAJSINGH SHEKHAWAT, et al.
Published: (2025-02-01)

WCN25-1387 DIFFUSE ALVEOLAR HEMORRHAGE AS AN ATYPICAL PRESENTATION FOR IgA NEPHROPATHY: CASE REPORT
by: José Fidel Véliz Escobar, et al.
Published: (2025-02-01)

WCN25-2980 ELECTROLYTE IMBALANCE AS A PRESENTING FEATURE IN IGA NEPHROPATHY: A CASE REPORT
by: Zafirah Zahir, et al.
Published: (2025-02-01)

WCN25-4034 ANCA mediated glomerular lesion on top of diabetic nephropathy, a case report
by: Sk Md Jaynul Islam, et al.
Published: (2025-02-01)

WCN25-892 RARE CASE OF PRTOEINURIC IGA NEPHROPATHY IN A PATIENT WITH IDIOPATHIC INTRACRANIAL HYPERTENSION
by: Sutanay Bhattacharyya
Published: (2025-02-01)

WCN25-3408 FIRST-AND SECOND-LINE THERAPY OF ZUBERITAMAB IN IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SINGLE-CENTER RETROSPECTIVE STUDY
by: wang linna, et al.
Published: (2025-02-01)

WCN25-1471 IgA Nephropathy with Anti-Neutrophil Cytoplasmic Antibodies in a Middle-Aged Patient
by: Giovanna Yazmin Arteaga Müller, et al.
Published: (2025-02-01)

WCN25-4604 EXOME ANALYSIS POINTS APOE4 HAPLOTYPE AS MAJOR RISK TO DEVELOP MESOAMERICAN NEPHROPATHY
by: Iván Landires, et al.
Published: (2025-02-01)

WCN25-4235 CHRONICITY SCORE AND NOT MEST C SCORE IS A BETTER PREDICTOR OF PROGNOSIS IN IGA NEPHROPATHY
by: TULSI MODI, et al.
Published: (2025-02-01)